BR9916417A - Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma - Google Patents
Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasmaInfo
- Publication number
- BR9916417A BR9916417A BR9916417-5A BR9916417A BR9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- sarcosystis
- neospora
- toxoplasma
- compounds
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 241001147660 Neospora Species 0.000 title abstract 2
- 241000223996 Toxoplasma Species 0.000 title abstract 2
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 201000005485 Toxoplasmosis Diseases 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 230000002036 metaphylactic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21871298A | 1998-12-22 | 1998-12-22 | |
| PCT/US1999/030284 WO2000037084A1 (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916417A true BR9916417A (pt) | 2001-11-06 |
Family
ID=22816194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916417-5A BR9916417A (pt) | 1998-12-22 | 1999-12-17 | Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1140101A1 (ko) |
| JP (1) | JP2002532552A (ko) |
| KR (1) | KR20010080571A (ko) |
| CN (1) | CN1331595A (ko) |
| AU (1) | AU2198100A (ko) |
| BR (1) | BR9916417A (ko) |
| CA (1) | CA2356181A1 (ko) |
| HK (1) | HK1043065A1 (ko) |
| HU (1) | HUP0104716A3 (ko) |
| NZ (1) | NZ512476A (ko) |
| WO (1) | WO2000037084A1 (ko) |
| ZA (1) | ZA200103919B (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9914385A (pt) | 1998-10-08 | 2001-07-17 | New Ace Res Company | Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais |
| DE19958388A1 (de) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten |
| DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
| DE10040110A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen |
| DE102007025908A1 (de) * | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
| DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
| CN102973497A (zh) * | 2012-12-13 | 2013-03-20 | 江苏恒丰强生物技术有限公司 | 一种托曲珠利溶液及其制备方法 |
| JP7350759B2 (ja) | 2018-02-26 | 2023-09-26 | アルゼキュア ファーマ アーべー | ニューロトロフィンに関連する疾患を治療するためのトリアジン誘導体 |
| GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998043644A1 (en) * | 1997-03-31 | 1998-10-08 | David Granstrom | Formulations and methods to treat and prevent equine protozoal myeloencephalitis |
-
1999
- 1999-12-17 KR KR1020017006550A patent/KR20010080571A/ko not_active Application Discontinuation
- 1999-12-17 EP EP99966449A patent/EP1140101A1/en not_active Withdrawn
- 1999-12-17 CA CA002356181A patent/CA2356181A1/en not_active Abandoned
- 1999-12-17 HU HU0104716A patent/HUP0104716A3/hu unknown
- 1999-12-17 AU AU21981/00A patent/AU2198100A/en not_active Abandoned
- 1999-12-17 BR BR9916417-5A patent/BR9916417A/pt not_active IP Right Cessation
- 1999-12-17 NZ NZ512476A patent/NZ512476A/en unknown
- 1999-12-17 JP JP2000589195A patent/JP2002532552A/ja active Pending
- 1999-12-17 WO PCT/US1999/030284 patent/WO2000037084A1/en not_active Application Discontinuation
- 1999-12-17 CN CN99815013A patent/CN1331595A/zh active Pending
-
2001
- 2001-05-15 ZA ZA200103919A patent/ZA200103919B/en unknown
-
2002
- 2002-07-05 HK HK02105041.6A patent/HK1043065A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0104716A2 (hu) | 2002-04-29 |
| WO2000037084A1 (en) | 2000-06-29 |
| HK1043065A1 (zh) | 2002-09-06 |
| EP1140101A1 (en) | 2001-10-10 |
| NZ512476A (en) | 2003-08-29 |
| CN1331595A (zh) | 2002-01-16 |
| CA2356181A1 (en) | 2000-06-29 |
| ZA200103919B (en) | 2002-05-15 |
| AU2198100A (en) | 2000-07-12 |
| HUP0104716A3 (en) | 2003-10-28 |
| KR20010080571A (ko) | 2001-08-22 |
| JP2002532552A (ja) | 2002-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2018C038I2 (ko) | ||
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| DE60036456D1 (de) | Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid | |
| ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
| BR9911094A (pt) | Composições e métodos para o tratamento detosse | |
| PT1140102E (pt) | Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma | |
| BR9916417A (pt) | Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma | |
| BR9604973A (pt) | Uma composição farmacêutica contendo carbamatos de n-cloro fenila e tiocarbamatos de n-cloro fenila para inibição de crescimento de vírus e cânceres | |
| BR9916391A (pt) | Compostos de triazineona para o tratamento de doenças causadas por sarcosiste, neopora e toxoplasma | |
| BR9815070A (pt) | Compostos tendo efeito inibitório da cgmp-pde | |
| BR0210401A (pt) | Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano | |
| BR9808263A (pt) | Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto. | |
| HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| BR0111014A (pt) | Compostos de praziquantel para o tratamento de doenças causadas por sarcocystis, neospora, toxoplasma e isospora | |
| BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto | |
| BR0210407A (pt) | Composto, composição farmacêutica, uso de um composto e método de tratamento de um distúrbio ou de uma doença de corpo animal vivo, incluindo um humano | |
| SE9803623D0 (sv) | New therapeutic application | |
| SI0872239T1 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
| BR0002260A (pt) | Métodos e composições para o tratamento de distúrbios relacionados com a idade, em animais de companhia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O E 7O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |